国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2013年
22期
3420-3421
,共2页
拜阿司匹灵%辛伐他汀%疗效
拜阿司匹靈%辛伐他汀%療效
배아사필령%신벌타정%료효
Bayaspirin%Simvastatin%Efficacy
目的 探讨拜阿司匹灵联合辛伐他汀治疗脑血栓形成患者的临床疗效.方法 112例脑血栓形成患者随机分为对照组和治疗组各56例.对照组:拜阿司匹灵0.1g,1次/天,安慰剂1片,1次/晚上;14天为1个疗程.治疗组:拜阿司匹灵0.1g,1次/天,辛伐他汀20 mg,1次/晚上;14天为1个疗程.比较两组患者的临床疗效.结果 对照组总有效率为87.50%,治疗组总有效率为94.64%;两组总有效率比较差异有统计学意义(P<0.05).结论 拜阿司匹灵联合辛伐他汀治疗脑血栓形成,能够显著改善患者临床症状及体征,促进神经功能恢复,未发现不良反应.
目的 探討拜阿司匹靈聯閤辛伐他汀治療腦血栓形成患者的臨床療效.方法 112例腦血栓形成患者隨機分為對照組和治療組各56例.對照組:拜阿司匹靈0.1g,1次/天,安慰劑1片,1次/晚上;14天為1箇療程.治療組:拜阿司匹靈0.1g,1次/天,辛伐他汀20 mg,1次/晚上;14天為1箇療程.比較兩組患者的臨床療效.結果 對照組總有效率為87.50%,治療組總有效率為94.64%;兩組總有效率比較差異有統計學意義(P<0.05).結論 拜阿司匹靈聯閤辛伐他汀治療腦血栓形成,能夠顯著改善患者臨床癥狀及體徵,促進神經功能恢複,未髮現不良反應.
목적 탐토배아사필령연합신벌타정치료뇌혈전형성환자적림상료효.방법 112례뇌혈전형성환자수궤분위대조조화치료조각56례.대조조:배아사필령0.1g,1차/천,안위제1편,1차/만상;14천위1개료정.치료조:배아사필령0.1g,1차/천,신벌타정20 mg,1차/만상;14천위1개료정.비교량조환자적림상료효.결과 대조조총유효솔위87.50%,치료조총유효솔위94.64%;량조총유효솔비교차이유통계학의의(P<0.05).결론 배아사필령연합신벌타정치료뇌혈전형성,능구현저개선환자림상증상급체정,촉진신경공능회복,미발현불량반응.
Objective To investigate the clinical efficacy of Bayaspirin combined with Simvastatin in the treatment of cerebral thrombosis.Methods 112 patients with cerebral thrombosis were divided into 56 cases in the control group and 56 cases in the treatment group.Control group:Bayaspirin 0.1g,1 time/day; 1 placebo tablet,1 time/night,14 days for 1 period of treatment.Treatment group:Bayaspirin 0.1g,1 time/day ; Simvastatin 20 mg,1 time/night,14 days for 1 period of treatment.The clinical efficacy in the two groups was compared.Results The total effective rate was 87.50% in the control group and 94.64% in the treatment group,the difference in the two groups was statistically significant (P < 0.05).Conclusion Bayaspirin combined with Simvastatin can significantly improve the clinical symptoms and signs of patients with cerebral thrombosis,promote the recovery of neurological function.No adverse reaction was found.